National Health Investors, Inc.
NHI Real Estate Reit Healthcare Facilities
National Health Investors, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $375.6 million, up 12.1% from fiscal 2024.
- Revenue
- +33.8%
- EPS
- +45.6%
- Free cash flow
- +2,585.5%
- Total debt
- +13.9%
Quarter to June 2026, against a year earlier
Follow NHI
Alert me
National Health Investors, Inc. (NHI) EV/Sales
As of 6 November 2026, National Health Investors, Inc. (NHI) trades at a EV/Sales of 10.8×. Over the past ten years it has ranged from 9.1× (March 2020) to 19.2× (January 2015); the current reading is higher than 4% of that period. That is above the Reit Healthcare Facilities industry median of 8.1× and above the Real Estate sector median of 7.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 12.6× | 1.33% |
| FY2024 | 12.4× | 12.52% |
| FY2023 | 11.0× | (12.16%) |
| FY2022 | 12.6× | (2.12%) |
| FY2021 | 12.8× | (6.10%) |
| FY2020 | 13.7× | (12.60%) |
| FY2019 | 15.6× | 3.61% |
| FY2018 | 15.1× | (0.86%) |
| FY2017 | 15.2× | (5.94%) |
| FY2016 | 16.2× | 16.13% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 11.4× | (10.96%) |
| Mar 2026 | 12.8× | 2.05% |
| Dec 2025 | 12.6× | (6.81%) |
| Sep 2025 | 13.5× | 7.57% |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| DHC Diversified Healthcare Trust compare | 3.0× |
| NHP National Healthcare Properties, Inc. compare | 4.0× |
| AHR American Healthcare REIT, Inc. compare | 5.1× |
| HR Healthcare Realty Trust Incorporated compare | 5.8× |
| LTC LTC Properties, Inc. compare | 8.1× |
| SBRA Sabra Healthcare REIT, Inc. compare | 8.5× |
| MPT Medical Properties Trust, Inc. compare | 9.4× |
| NHI National Health Investors, Inc. | 10.8× |
| CTRE CareTrust REIT, Inc. compare | 17.5× |
| Reit Healthcare Facilities industry median | 8.1× |
| Real Estate sector median | 7.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on NHI
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- The full statement